Full Face 2025 – International Congress of Medical Aesthetics

At the D-MED Full Face Congress 2025
A Visionary Approach to Regenerative Medicine and Autologous Exosomes

Founder of D-MED & T-LAB Timur Veysel Doğruok, MBA,

Full Face 2025 Congress within the scope of

“The Future of the Industry: Regenerative Medicine and Autologous Exosomes” in his/her speech,

the rapidly developing field of regenerative medicine with its innovative treatment protocols,

He addressed the transformative effects of modern medical applications.

Doğruok, drawing attention to the strategic position of biotechnology in the future of medical science,

He spoke about the contributions of D MED's pioneering work in this field to the international health ecosystem.

Conversation Focus Points

WhatsApp Image 2025 08 29 at 14.12.04

On the Full Face 2025 stage, regenerative medicine is not just a treatment method,

Doğruok emphasized that it is also the foundation of sustainable transformation in health,

Shared the effectiveness of otological exosome technologies in clinical applications with real case examples.

The New Era in Regenerative Medicine

Cellular regeneration and biotechnological solutions are going beyond classic treatment approaches.

Clinical Impact of Otologic Exosomes

Exosomes derived from the patient's own biological resources,

It speeds up recovery processes naturally and safely.

From Scientific Data to Application

Translating laboratory findings into clinical success in the field requires a multidisciplinary approach.

The Future of the Industry and Global Standards

Regenerative medicine requires the construction of a system based not only on health, but also on ethics, technology, and education.

Key Takeaways from the Congress

WhatsApp Image 2025 08 29 at 14.12.03 1

The session, held with the active participation of expert physicians in their fields,
has become a platform for sharing important ideas shaping the future of regenerative medicine technologies in medical aesthetics and clinical applications.

96%
Participants evaluated the session as “informative and innovative.”.
88%
Physicians noted an increase in the knowledge level regarding autologous exosome applications.
84%
Participants stated that D-MED's leadership in the sector has raised the standard.
WhatsApp Image 2025-08-29 at 2.12.02 PM 2

When you combine science and technology, you can not only cure —
At the same time, you build the healthcare ecosystem of the future.

Timur Veysel Doğruok, Founder, D-MED | T-LAB | T-LAB Academy